Evidence behind the WHO guidelines: Hospital Care for Children: efficacy and safety of artemisinin derivatives in children with malaria.
Bar-Zeev
Naor
N
Royal Children's Hospital, Melbourne, Australia.
White
Nick
N
D000293:Adolescent; D000328:Adult; D000818:Animals; D000890:Anti-Infective Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000962:Antimalarials / Q000009:adverse effects / Q000627:therapeutic use*; D037621:Artemisinins / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D006760:Hospitalization; D006801:Humans; D016778:Malaria, Falciparum / Q000188:drug therapy* / Q000453:epidemiology / Q000401:mortality; D015201:Meta-Analysis as Topic; D010963:Plasmodium falciparum / Q000187:drug effects* / Q000254:growth & development; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D012717:Sesquiterpenes / Q000009:adverse effects / Q000627:therapeutic use*; D014944:World Health Organization
D000890:Anti-Infective Agents; D000962:Antimalarials; D037621:Artemisinins; D012717:Sesquiterpenes; C031327:artemisinin